Nanotechnology cancer treatments include the detection and eradication of cancer cells before they form tumors, as well as the destruction of cancer tumors with little damage to healthy tissue and organs. Nanotechnology offers enormous opportunities in cancer therapy, diagnostics, and imaging, but bridging the translational gap is a difficult task. The majority of nanomedicine research is focused on cancer. The enhanced permeability and retention effect causes nanoparticles to selectively concentrate in solid tumors due to the presence of leaky vasculature and reduced lymphatic drainage. As a result, nanoparticles are ideal for delivering diagnostic and/or imaging agents, chemotherapeutics, oligonucleotides, and immune regulators in order to improve their therapeutic index. The majority of nanotechnology cancer treatment attempts are still in the research or development stages. Many colleges and businesses around the world, however, are working in this field.
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
